ArticleCancer immunology research2026

Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.

Sora Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.